Journal of Medical Physics
TECHNICAL NOTE
Year
: 2022  |  Volume : 47  |  Issue : 4  |  Page : 394--397

Reporting of inter fraction dose variations of organs at risk in computed tomography-guided high dose rate intracavitary brachytherapy in carcinoma cervix


Moujhuri Nandi, Neelima Pokala, Vaishnavi Perumareddy, Sujata Sarkar, Sudeep Chanda 
 Department of Radiation Oncology, Meherbai Tata Memorial Hospital, Jamshedpur, Jharkhand, India

Correspondence Address:
Dr. Moujhuri Nandi
Meherbai Tata Memorial Hospital, Northern Town, Stocking Road, Bistupur, Purbi Singbhum, Jamshedpur - 831 001, Jharkhand
India

Assess the interfraction dose variations of the organs at risk (OARs) in carcinoma cervix high dose rate (HDR) computed tomography (CT)-guided intra cavitary brachytherapy (ICBT). 120 CT scans of 40 patients who had undergone three fractions of ICBT (7 Gy/fr) were analyzed. Dose to Point A and the minimum doses to the volumes of 2, 1, and 0.1cc of bladder, rectum and sigmoid colon were recorded. Revised plans were generated in 20 patients. Paired t-test was used to compare the difference in the means. Point “A” mean dose difference was statistically significant between the treated and revised plans. For bladder, the difference in means of dosage to all volumes, whilst for the rectum and sigmoid colon, the low volume dosage (0.1cc) was statistically significant. Absence of individualized planning would have resulted in underdosage of tumor and increased dosage of up to 30% to OARs. CT-guided ICBT should be implemented for each HDR fraction treatment.


How to cite this article:
Nandi M, Pokala N, Perumareddy V, Sarkar S, Chanda S. Reporting of inter fraction dose variations of organs at risk in computed tomography-guided high dose rate intracavitary brachytherapy in carcinoma cervix.J Med Phys 2022;47:394-397


How to cite this URL:
Nandi M, Pokala N, Perumareddy V, Sarkar S, Chanda S. Reporting of inter fraction dose variations of organs at risk in computed tomography-guided high dose rate intracavitary brachytherapy in carcinoma cervix. J Med Phys [serial online] 2022 [cited 2023 Mar 28 ];47:394-397
Available from: https://www.jmp.org.in/article.asp?issn=0971-6203;year=2022;volume=47;issue=4;spage=394;epage=397;aulast=Nandi;type=0